Applied Dna Sciences Inc (APDN) USD0.001

Sell:$0.13Buy:$0.13$0.00 (1.01%)

Prices delayed by at least 15 minutes
Sell:$0.13
Buy:$0.13
Change:$0.00 (1.01%)
Prices delayed by at least 15 minutes
Sell:$0.13
Buy:$0.13
Change:$0.00 (1.01%)
Prices delayed by at least 15 minutes

Company Information

About this company

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

Key people

James A. Hayward
Chairman of the Board, Chief Executive Officer
Judith Murrah
President
Beth M. Jantzen
Chief Financial Officer
Robert B. Catell
Independent Director
Joseph D. Ceccoli
Independent Director
Elizabeth M. Schmalz Shaheen
Independent Director
Yacov A. Shamash
Independent Director
Sanford R. Simon
Independent Director
Click to see more

Key facts

  • EPIC
    APDN
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US03815U4094
  • Market cap
    $7.06m
  • Employees
    46
  • Shares in issue
    55.19m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.